DPI developer Iconovo has announced that Galenica AB will offer cGMP manufacturing of Iconovo's ICOone single dose disposable DPI for clinical trials, so that customers wanting to develop an inhaled drug delivered by the ICOone device have an accelerated option for producing clinical trial supplies. According to the announcement, close cooperation between the … [Read more...] about Galenica to provide GMP manufacturing for clinical trial supplies of Iconovo’s ICOone inhaler
Products and Services
Proveris names Ramesh Chand as Associate Director of Proveris Laboratories
Proveris Scientific has named Ramesh Chand as Associate Director of Proveris Laboratories, the company's contract testing business, which launched in May 2020. Chand was most recently Principal Scientist in Respiratory Drug Product Development at Moderna and previously held positions in OINDP research at GSK, Lovelace Biomedical, and Amneal … [Read more...] about Proveris names Ramesh Chand as Associate Director of Proveris Laboratories
Kindeva Drug Delivery acquires iPharma Labs
Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, has announced that it will acquire inhaled drug CRO iPharma Labs, and iPharma's team of well-known OINDP specialists will join Kindeva. Founded in 2016, iPharma extended its offerings in 2020 to include GLP/GMP development services for inhaled drugs. The iPharma team will remain in its existing facilities in … [Read more...] about Kindeva Drug Delivery acquires iPharma Labs
Copley Scientific launches Gentle Rocker 100i sample recovery system for the NGI
Copley Scientific has announced the launch of the Gentle Rocker 100i device for faster sample recovery from the Next Generation Impactor (NGI). According to Copley, the Gentle Rocker 100i offers controlled agitation of the entire NGI collection cup tray, with agitation speeds from 10 to 60 rpm and a tilting function for easier solution sampling and "enables the … [Read more...] about Copley Scientific launches Gentle Rocker 100i sample recovery system for the NGI
Catalent adds nasal spray manufacturing capacity
CDMO Catalent, which offers services for a full range of OINDPs, has announced the completion of the first phase of "a significant expansion" of its development and manufacturing capabilities for unit dose and bi-dose nasal sprays at its facility in Morrisville, NC, USA. The new additions include a high speed micro vial filling line and a high speed assembly line, the … [Read more...] about Catalent adds nasal spray manufacturing capacity
Recipharm launches services for transitioning MDIs to lower-GWP propellants
CDMO Recipharm said that it is now offering services for reformulation of MDIs with new lower global warming potential propellants such as HFA 152a and HFO 1234ze. The company also announced that it has partnered with Prof. Darragh Murnane at the University of Hertfordshire for development of technology around the transition to lower-GWP propellants. The … [Read more...] about Recipharm launches services for transitioning MDIs to lower-GWP propellants
Inke to triple inhalation API manufacturing capacity
Inhalation API manufacturer Inke has announced a €9 million expansion of its manufacturing facility in Castellbisbal, Barcelona, Spain "to reinforce focus on inhalation micronized APIs," with the aim of tripling its production capacity by 2024. According to Inke, the site currently makes 34 APIs for pharma companies in the US, Europe, Turkey, Japan, China, and Korea, … [Read more...] about Inke to triple inhalation API manufacturing capacity
Upperton Pharma Solutions launches nasal delivery development platform
UK-based CDMO Upperton Pharma Solutions has launched a nasal delivery development platform called UpperNose, the company said. The UpperNose services include pre-formulation analyses, dosage form selection, and formulation and process development through to clinical trial manufacturing. Upperton Chief Scientific Officer Richard Johnson said, "The delivery of … [Read more...] about Upperton Pharma Solutions launches nasal delivery development platform
Lonza joins IPAC-RS
CDMO Lonza has joined the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS), the company said. In the announcement of its IPAC-RS membership, Lonza specifically noted its planned participation in discussions related to particle engineering, inhaler testing, devices, and packaging. In July 2020, Lonza announced that it had … [Read more...] about Lonza joins IPAC-RS
Koura opens HFA 152a production facility
Koura has officially opened a new facility for the production of HFA 152a in Runcorn, UK, the company announced. According to Koura, the propellant produced at the facility, which will be marketed as "Zephex 152a," will be available at commercial scale within a few months. In December 2019, Italian pharma company Chiesi said that it had signed an agreement with … [Read more...] about Koura opens HFA 152a production facility